The efficacy of a nitric oxide-releasing formulation on nares isolated Methicillin-Resistant Staphylococcus aureus in porcine wound infection model
2024

Nitric Oxide Treatment for MRSA in Pigs

Sample size: 3 publication Evidence: high

Author Information

Author(s): Davis Stephen C., Gil Joel, Solis Michael, Strong Ryan

Primary Institution: University of Miami Miller School of Medicine

Hypothesis

The study investigates the efficacy of a nitric oxide-releasing formulation against Methicillin-Resistant Staphylococcus aureus (MRSA) in a porcine wound infection model.

Conclusion

The study found that the nitric oxide formulation significantly reduced MRSA bacterial counts, with the highest concentration being the most effective.

Supporting Evidence

  • The 1.8% nitric oxide formulation reduced more than 99% of bacterial counts compared to baseline.
  • Mupirocin 2% was the overall best treatment against MRSA on both assessment days.
  • Significant reductions in MRSA were observed with all nitric oxide concentrations compared to untreated controls.

Takeaway

This study tested a special ointment that releases nitric oxide to see if it can help fight a stubborn germ called MRSA in pig wounds, and it worked really well!

Methodology

The study used a porcine model with deep partial-thickness wounds infected with MRSA, treated with various concentrations of nitric oxide ointments.

Potential Biases

The study received funding from Novan Inc., which may introduce potential bias.

Limitations

The study was limited to a porcine model and did not evaluate the effects on wound healing.

Participant Demographics

Three young female specific-pathogen-free Yorkshire pigs, aged 2-3 months and weighing 35-40 kg.

Statistical Information

P-Value

p ≤ 0.05

Statistical Significance

p ≤ 0.05

Digital Object Identifier (DOI)

10.3389/fcimb.2024.1501360

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication